NKG2D-CAR-NK92 Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NKG2D-CAR-NK92 Cells, covering 2025-04-10 to 2025-04-10. Get the full timeline:
Most recent: Clinical Trial Update: NKG2D-CAR-NK92 Cells Immunotherapy for Solid Tumors [Phase 1]